Clinical Trials Logo

Clinical Trial Summary

The purpose of the study is to establish a high-sensitivity troponin 0h/1h process for the diagnosis of patients suspected of NSTEMI for the Chinese population, obtain the inclusion and exclusion criteria for diagnosis of these patients and compare the new process with the existing diagnosing methods and processes, including the 3h and 6h processes more extensively used at present and the ECG combined with troponin diagnosis, so as to explore a confirmation model suitable for the Chinese population.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03331549
Study type Observational
Source Beijing Anzhen Hospital
Contact Shao-Ping Nie, MD,PhD
Phone 86-10-84005256
Email spnie@126.com
Status Recruiting
Phase N/A
Start date July 21, 2017
Completion date June 30, 2018

See also
  Status Clinical Trial Phase
Terminated NCT02543177 - Optimised Procedure in Patients With NSTEMI and CKD N/A
Completed NCT01826552 - Comparison of the Angiographic Result of the Orsiro Hybrid Stent With Resolute Integrity Stent Phase 4
Not yet recruiting NCT02868203 - OCT Based Edge and In-stent Vascular Response After Cordimax Stent in patIents With NSTE-ACS Phase 4
Completed NCT02217878 - Influence of Morphine on Pharmacokinetics and Pharmacodynamics of Ticagrelor in Patients With Acute Myocardial Infarction Phase 4